Literature DB >> 21602168

Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients.

Miguel Galicia1, Santiago Nogue, Oscar Miró.   

Abstract

BACKGROUND: To describe the epidemiological profile and clinical manifestations of liquid ecstasy (GHB) poisonings.
METHODS: All cases of GHB poisoning or overdose admitted to the Emergency Department (ED) of the Hospital Clinic (Barcelona) between 2000 and 2007 were recorded.
RESULTS: A total of 505 patients (mean age 24.7 years, 68% men) were included. Most patients were brought to the hospital by ambulance (98%), during the weekend (89%) and during the early morning (75%). Symptoms began in a public place in 97%. Reduced consciousness was the most important clinical manifestation: 72% of patients had a Glasgow Coma Score of ≤ 12. 76% of patients had consumed other drugs: ethanol (64%), amphetamines and derivates (30%), cocaine (28%), ketamine (11%), cannabis (9%) and others (5%). Treatment was required in 26% of cases and an antidote was administered in 35 cases with no response. There were no deaths. The combined GHB group had a longer time to complete recovery of consciousness (71 ± 40 vs 59 ± 40 min, p < 0.001) and a higher percentage of patients with severely reduced consciousness at ED arrival (54% vs 37%, p = 0.01), need for treatment (29% vs 16%, p < 0.01) and need for mechanical ventilation (3% vs 0%, p < 0.05) compared with the pure GHB group.
CONCLUSIONS: GHB intoxication leading to reduced consciousness is a frequent reason for ED admission, above all in young people and in the early morning at the weekend. Symptoms are more severe in patients who have taken GHB in combination with other substances of abuse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602168     DOI: 10.1136/emj.2008.068403

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  13 in total

Review 1.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

2.  Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.

Authors:  Bridget L Morse; Gurkishan S Chadha; Melanie A Felmlee; Kristin E Follman; Marilyn E Morris
Journal:  Am J Drug Alcohol Abuse       Date:  2017-06-29       Impact factor: 3.829

3.  γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.

Authors:  Rutwij A Dave; Kristin E Follman; Marilyn E Morris
Journal:  AAPS J       Date:  2017-06-26       Impact factor: 4.009

4.  A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.

Authors:  Nisha Vijay; Bridget L Morse; Marilyn E Morris
Journal:  Pharm Res       Date:  2014-12-06       Impact factor: 4.200

5.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

6.  Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies.

Authors:  Bridget L Morse; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2013-06-28       Impact factor: 4.030

7.  γ-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose.

Authors:  Bridget L Morse; Nisha Vijay; Marilyn E Morris
Journal:  Mol Pharmacol       Date:  2012-05-04       Impact factor: 4.436

Review 8.  GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.

Authors:  Francesco P Busardò; Alan W Jones
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

9.  Toxicokinetic/Toxicodynamic Interaction Studies in Rats between the Drugs of Abuse γ-Hydroxybutyric Acid and Ketamine and Treatment Strategies for Overdose.

Authors:  Nisha V Kwatra; Marilyn E Morris
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

10.  Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: a case series.

Authors:  Michael Bodmer; Florian Enzler; Evangelia Liakoni; Marcel Bruggisser; Matthias E Liechti
Journal:  BMC Res Notes       Date:  2014-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.